Clinical Trials for PDS Biotechnology

Explore 1 clinical trials worldwide

Showing 1-1 of 1 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: PDS Biotechnology

Clinical Trials (1)

NCT06790966
Phase 3 Study of PDS0101 and Pembrolizumab in HPV16+ Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma
PHASE3Recruiting
351 participants
Started: May 30, 2025 · Completed: Feb 28, 2029
5 conditions1 sponsor21 locations